充血型肺动脉高压中肺血管平滑肌增殖新机制-GPR91研究

基本信息
批准号:81370277
项目类别:面上项目
资助金额:65.00
负责人:莫绪明
学科分类:
依托单位:南京医科大学
批准年份:2013
结题年份:2017
起止时间:2014-01-01 - 2017-12-31
项目状态: 已结题
项目参与者:朱棠,杨磊,束亚琴,富智,郁迪,杨玉忠,林泽邦,冯宇
关键词:
平滑肌增殖G蛋白偶联受体91肺动脉高压磷脂酰肌醇3激酶/蛋白激酶B
结项摘要

Congestive pulmonary arterial hypertension(cPAH)remains a major complication of congenital heart disease(CHD) characterized by increasing proliferation of vascular smooth muscle cells. The fundamental paphological changes,such as PI3K/AKT activation, usually result in vascular remodeling and plexus and eventually lead to right heart failure, or even death. Our preliminary study suggested that the activation of GPR91 in rat pulmonary hypertension model. We hypothesis that GPR91 play an important role during the pulmonary hypertension pathological processes caused by PI3K/AKT activation. Therefore, our project will continue observe: i) GPR91 receptor expression, function regulation, signaling transduction in rat pulmonary hypertension model; ii) GPR91gene expression and histoimmunochemical analysis in myocardial biopsy in cPAH model and smooth muscle cells; iii) cellular proliferation, migration and angiogenic factor expression induced by GPR91 in pulmonary artery smooth muscle cells and vascular endothelial cells; iv) the functional regulation of GPR91 by gene expression, signaling inhibition, gene knock down on above experiments in vivo and in vitro. This study aim to test GPR91 receptor as the main role to cause cPAH, and try to find a new mechanism of cPAH as well as new methods to prevent and control the morbidity and the mortality of cPAH.

充血性肺动脉高压(cPAH)是先心病常见危重并发症之一,其主要发病机制是肺充血导致肺血管平滑肌增殖、血管重构。GPR91是新近发现调控血管生长和功能的膜受体。前期研究基础表明激活肺动脉GPR91后血管平滑肌磷脂酰肌醇3-激酶/蛋白激酶B (PI3K/AKT) 活化,进而引起血管平滑肌增殖、动脉重构,我们推测在cPAH患者中,GPR91同样通过激活PI3K/AKT进而导致肺动脉平滑肌增殖、动脉重构,从而在cPAH的形成中发挥重要作用。本研究拟观察在cPAH动物模型及离体平滑肌细胞培养中GPR91对肺动脉平滑肌细胞PI3K/AKT及增殖、分化、凋亡的影响;进一步研究其影响血管平滑肌增殖、分化、凋亡分子机制;同时,利用GPR91基因敲除cPAH模型,观察敲除该基因对cPAH发生发展的影响。本课题研究具有源头创新性,可为先心病患儿cPAH的防治提供新的靶标。

项目摘要

充血性肺动脉高压(cPAH)是先心病常见危重并发症之一,其主要发病机制是肺充血导致肺血管平滑肌增殖、血管重构。GPR91是新近发现调控动脉生长和重构的膜受体。前期研究表明激活肺GPR91后血管平滑肌肾素-血管紧张素-醛固酮系统(RAAS)表达上调,进而血管平滑肌增殖,动脉重构,提示GPR91可能通过激活RAAS进而导致肺动脉重构,从而在cPAH的形成中发挥重要作用。本研究发现观察在cPAH动物模型及离体平滑肌细胞培养中GPR91对肺动脉RAAS及平滑肌的增殖具有激活影响; GPR91对RAAS及平滑肌增殖、分化、凋亡、迁移均有促进影响;进一步研究发现影响血管平滑肌变化、动脉重构的分子机制与PI3K/AKT有关;同时,利用GPR91基因敲除cPAH模型,观察到敲除该基因对cPAH具有减轻肺动脉平滑肌增殖的影响。本课题研究具有源头创新性,可为先心病患儿cPAH的防治提供新的靶标。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

Protective effect of Schisandra chinensis lignans on hypoxia-induced PC12 cells and signal transduction

Protective effect of Schisandra chinensis lignans on hypoxia-induced PC12 cells and signal transduction

DOI:10.1080/15287394.2018.1502561
发表时间:2018
2

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

Efficient photocatalytic degradation of organic dyes and reaction mechanism with Ag2CO3/Bi2O2CO3 photocatalyst under visible light irradiation

DOI:
发表时间:2016
3

基于 Kronecker 压缩感知的宽带 MIMO 雷达高分辨三维成像

基于 Kronecker 压缩感知的宽带 MIMO 雷达高分辨三维成像

DOI:10.11999/JEIT150995
发表时间:2016
4

Engineering Leaf-Like UiO-66-SO_3H Membranes for Selective Transport of Cations

Engineering Leaf-Like UiO-66-SO_3H Membranes for Selective Transport of Cations

DOI:10.1007/s40820-020-0386-6
发表时间:2020
5

The Role of Osteokines in Sarcopenia: Therapeutic Directions and Application Prospects

The Role of Osteokines in Sarcopenia: Therapeutic Directions and Application Prospects

DOI:10.3389/fcell.2021.735374
发表时间:2021

莫绪明的其他基金

相似国自然基金

1

肺动脉平滑肌细胞衰老:低氧诱导肺动脉高压肺血管重构的新机制

批准号:81600040
批准年份:2016
负责人:王爱平
学科分类:H0107
资助金额:18.00
项目类别:青年科学基金项目
2

Twist1在血管平滑肌细胞增殖和肺动脉高压肺血管重塑中的作用及机制研究

批准号:81873414
批准年份:2018
负责人:范晔
学科分类:H0107
资助金额:57.00
项目类别:面上项目
3

HDAC4/MEF2C对肺动脉高压肺血管平滑肌增殖调控的实验研究

批准号:81600388
批准年份:2016
负责人:张维
学科分类:H0211
资助金额:17.50
项目类别:青年科学基金项目
4

PDGF对肺血管平滑肌细胞增殖的调控作用研究

批准号:39470301
批准年份:1994
负责人:孙仁宇
学科分类:H0107
资助金额:7.00
项目类别:面上项目